Glioma Clinical Trial
Official title:
The Experience of Informal Caregivers of Patients With Brain Tumors
The objective of this study is to explore the experience of informal caregivers of patients with a primary brain tumor, identifying elements and themes of the caregiving experience specific to this population of caregivers. The aim is to describe the experience of being an informal caregiver for a patient with a primary brain tumor.
Caregiver Consent:
If you agree to take part in this study, you will be asked to have 1 interview. This will be
a face-to-face interview that will take place at M. D. Anderson while you are there for the
patient's physician appointment.
During this interview, you will be asked to describe what it has been like for you to help
care for a person with a primary brain tumor in the past, what it is like to care for a
person with a primary brain tumor now, and what you think it might be like in the future.
You will be interviewed alone, and your interview will be tape recorded and then written on
paper. The information that is gathered (the tape and the written information) will be kept
strictly confidential. The tapes and any paperwork will be kept in a locked box during and
after this study. The written information will be kept in password-protected computer files.
The researcher is the only person who will have access to the tapes. You will also be asked
to answer a questionnaire on paper. This questionnaire will ask specific personal
information, such as your age, occupation, and relationship to the patient. This
questionnaire will take about 5 minutes to complete. The entire interview will take about 30
minutes to complete.
Your participation in this study will be over after you complete the interview and the
questionnaire.
This is an investigational study. Up to 20 caregivers will take part in this study. All will
be enrolled at M. D. Anderson.
Patient Consent:
If you agree to take part in this study, you will be asked to choose a family member or a
friend who is your main caregiver and who may be willing to take part in 1 interview for
this study. Your consent in this study, will give researchers permission to contact your
caregiver. If your caregiver chooses to participate, the interview will be face-to-face, and
it will take place at M. D. Anderson while you are there for your physician appointment.
During this interview, the caregiver will be asked to describe what it has been like for
them to help care for you. The researcher will get informed consent from your caregiver and
will go into further detail about this study.
He or she will be interviewed alone, and the information gathered during the interview will
be kept strictly confidential. Your caregiver will be asked to complete a questionnaire for
specific personal information, such as his or her age, occupation, and relationship to you.
The entire interview will take about 30 minutes to complete.
You will be asked to allow your sociodemographic data (such as your gender, marital status,
etc.) and medical data (such as your diagnosis, therapies received, etc.) to be collected
from your medical record. This information will be used to help researchers learn about the
unique backgrounds of the patients participating in this study. Your information that is
gathered will be kept strictly confidential, and it will be kept in a locked box during and
after this study.
Your participation in this study will be over after your sociodemographic and medical data
have been collected from your medical record.
This is an investigational study. Up to 20 patients will take part in this study. All will
be enrolled at M. D. Anderson.
;
Observational Model: Case-Only, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT04539574 -
An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors
|
N/A | |
| Enrolling by invitation |
NCT04461002 -
Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.
|
||
| Terminated |
NCT01902771 -
Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
|
Phase 1 | |
| Completed |
NCT03242824 -
The Utility of 18F-DOPA-PET in the Treatment of Recurrent High-grade Glioma
|
Phase 2 | |
| Recruiting |
NCT04186832 -
Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy
|
N/A | |
| Completed |
NCT00424554 -
Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed)
|
Phase 2 | |
| Recruiting |
NCT05968053 -
Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
|
||
| Not yet recruiting |
NCT04550663 -
NKG2D CAR-T(KD-025) in the Treatment of Relapsed or Refractory NKG2DL+ Tumors
|
Phase 1 | |
| Completed |
NCT02805179 -
A Study of High-Dose Chemoradiation Using Biologically-Based Target Volume Definition in Patients With Glioblastoma
|
Phase 2 | |
| Terminated |
NCT04556929 -
Enhanced Detection in Glioma Excision
|
N/A | |
| Not yet recruiting |
NCT06408428 -
Glioma Intraoperative MicroElectroCorticoGraphy
|
N/A | |
| Recruiting |
NCT06043232 -
MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas
|
||
| Not yet recruiting |
NCT06043765 -
Reducing Cognitive Impairment in Glioma With Repetitive Transcranial Magnetic Stimulation and Cognitive Strategy Training
|
N/A | |
| Not yet recruiting |
NCT05025969 -
Evaluation of the Incidence of NTRK Gene Fusion in Adult Brain Tumours
|
||
| Completed |
NCT02978261 -
Study of a c-Met Inhibitor PLB1001 in Patients With PTPRZ1-MET Fusion Gene Positive Recurrent High-grade Gliomas
|
Phase 1 | |
| Terminated |
NCT01502605 -
Phase I Study of Orally Administered Aminolevulinic Acid for Resection of Malignant Astrocytomas
|
Phase 1 | |
| Completed |
NCT01836536 -
Search for a Link Between Response to Treatment and Circulating Leucocytes in High Grade Glioma Patients
|
N/A | |
| Completed |
NCT01479686 -
iMRI Guided Resection in Cerebral Glioma Surgery
|
Phase 3 | |
| Completed |
NCT01212731 -
Skull Base and Low Grade Glioma Neurocognitive Magnetic Resonance Imaging (MRI) Study
|
||
| Withdrawn |
NCT00985036 -
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
|
N/A |